INR 51.69
(3.44%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 78.67 Million INR | -11.1% |
2022 | 88.5 Million INR | -22.58% |
2021 | 114.32 Million INR | -6.47% |
2020 | 122.22 Million INR | -7.62% |
2019 | 132.3 Million INR | -0.94% |
2018 | 133.55 Million INR | 7.93% |
2017 | 123.74 Million INR | -35.11% |
2016 | 190.69 Million INR | 45.06% |
2015 | 131.46 Million INR | 116.71% |
2014 | 60.66 Million INR | -14.22% |
2013 | 70.72 Million INR | 31.05% |
2012 | 53.96 Million INR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 Q1 | 21.77 Million INR | -75.4% |
2023 Q2 | 71.24 Million INR | 227.26% |
2023 FY | 78.67 Million INR | -11.1% |
2023 Q3 | 86.21 Million INR | 21.0% |
2023 Q4 | 78.67 Million INR | -8.74% |
2022 FY | 88.5 Million INR | -22.58% |
2022 Q3 | 11.99 Million INR | -91.31% |
2022 Q1 | 23.43 Million INR | -79.5% |
2022 Q2 | 138.02 Million INR | 488.86% |
2022 Q4 | 88.5 Million INR | 637.89% |
2021 Q2 | 106.09 Million INR | 0.0% |
2021 FY | 114.32 Million INR | -6.47% |
2021 Q4 | 114.32 Million INR | 0.0% |
2020 FY | 122.22 Million INR | -7.62% |
2020 Q2 | 120.73 Million INR | 0.0% |
2020 Q1 | 120.73 Million INR | -8.75% |
2020 Q4 | 122.22 Million INR | 0.02% |
2020 Q3 | 122.2 Million INR | 1.22% |
2019 Q4 | 132.3 Million INR | 6.2% |
2019 Q1 | 145.23 Million INR | 8.75% |
2019 Q3 | 124.57 Million INR | -14.22% |
2019 Q2 | 145.23 Million INR | 0.0% |
2019 FY | 132.3 Million INR | -0.94% |
2018 Q4 | 133.55 Million INR | 3.49% |
2018 FY | 133.55 Million INR | 7.93% |
2018 Q3 | 129.05 Million INR | 13.28% |
2018 Q2 | 113.92 Million INR | 0.0% |
2018 Q1 | 113.92 Million INR | -7.94% |
2017 FY | 123.74 Million INR | -35.11% |
2017 Q1 | 186.34 Million INR | -2.28% |
2017 Q2 | 186.34 Million INR | -0.0% |
2017 Q3 | 117.65 Million INR | -36.86% |
2017 Q4 | 123.74 Million INR | 5.17% |
2016 FY | 190.69 Million INR | 45.06% |
2016 Q4 | 190.69 Million INR | 0.0% |
2015 FY | 131.46 Million INR | 116.71% |
2014 FY | 60.66 Million INR | -14.22% |
2013 FY | 70.72 Million INR | 31.05% |
2012 FY | 53.96 Million INR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Ajanta Pharma Limited | -954.9 Million INR | 108.239% |
Amrutanjan Health Care Limited | -248.79 Million INR | 131.624% |
Sigachi Industries Limited | 859.94 Million INR | 90.851% |
Bal Pharma Limited | 1.26 Billion INR | 93.773% |
Ind-Swift Laboratories Limited | -4.15 Billion INR | 101.894% |
Lasa Supergenerics Limited | 205.79 Million INR | 61.77% |
Venus Remedies Limited | -267.7 Million INR | 129.39% |
Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 108.354% |
Alpa Laboratories Limited | 35.36 Million INR | -122.484% |
Nectar Lifesciences Limited | 6.15 Billion INR | 98.722% |
Shilpa Medicare Limited | 9.06 Billion INR | 99.133% |
Aarti Drugs Limited | 5.54 Billion INR | 98.582% |
Lupin Limited | 17.19 Billion INR | 99.542% |
Aurobindo Pharma Limited | 3.69 Billion INR | 97.87% |
Zydus Lifesciences Limited | 3.91 Billion INR | 97.989% |
Windlas Biotech Limited | -273.04 Million INR | 128.815% |
Suven Life Sciences Limited | -1.63 Billion INR | 104.819% |
Eris Lifesciences Limited | 13.8 Billion INR | 99.43% |
Valiant Laboratories Limited | -295.03 Million INR | 126.667% |
J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 97.211% |
Solara Active Pharma Sciences Limited | 10.02 Billion INR | 99.216% |
Ipca Laboratories Limited | 11.41 Billion INR | 99.311% |
Bliss GVS Pharma Limited | -1.15 Billion INR | 106.796% |
Achyut Healthcare Limited | -3.74 Million INR | 2200.294% |
Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 100.109% |
Bajaj HealthCare Limited | 3.29 Billion INR | 97.615% |
RPG Life Sciences Limited | -364.7 Million INR | 121.573% |
Mankind Pharma Limited | -9.9 Billion INR | 100.794% |
Laurus Labs Limited | 24.38 Billion INR | 99.677% |
Piramal Pharma Limited | 42.27 Billion INR | 99.814% |
Syncom Formulations (India) Limited | 46.21 Million INR | -70.256% |
Torrent Pharmaceuticals Limited | 31.83 Billion INR | 99.753% |
Alembic Pharmaceuticals Limited | 3.86 Billion INR | 97.965% |
Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 101.836% |
Unichem Laboratories Limited | 931.91 Million INR | 91.558% |
Sequent Scientific Limited | 4.17 Billion INR | 98.117% |
Novartis India Limited | -5.89 Billion INR | 101.336% |
Wanbury Limited | 1.1 Billion INR | 92.886% |
Suven Pharmaceuticals Limited | 144.97 Million INR | 45.731% |
Wockhardt Limited | 18.27 Billion INR | 99.569% |
Themis Medicare Limited | 764.96 Million INR | 89.715% |
Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 105.661% |
Jubilant Pharmova Limited | 27.07 Billion INR | 99.709% |
Glenmark Life Sciences Limited | -2.84 Billion INR | 102.768% |
Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 99.391% |
Divi's Laboratories Limited | -39.77 Billion INR | 100.198% |
NATCO Pharma Limited | -5.81 Billion INR | 101.353% |
Gufic Biosciences Limited | 3.19 Billion INR | 97.537% |
IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 107.144% |
Ind-Swift Limited | 9.5 Billion INR | 99.173% |
Procter & Gamble Health Limited | -2.34 Billion INR | 103.351% |
FDC Limited | -57.75 Million INR | 236.233% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 95.93% |
Granules India Limited | 9.28 Billion INR | 99.153% |
Medicamen Biotech Limited | 160.31 Million INR | 50.924% |
Alkem Laboratories Limited | -1.6 Billion INR | 104.889% |
AstraZeneca Pharma India Limited | -5.01 Billion INR | 101.57% |
Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 526.526% |
Brooks Laboratories Limited | 49.48 Million INR | -58.992% |
Megasoft Limited | 1.28 Billion INR | 93.88% |
ZIM Laboratories Limited | 983.6 Million INR | 92.001% |
Strides Pharma Science Limited | 23.25 Billion INR | 99.662% |
Neuland Laboratories Limited | -214.05 Million INR | 136.755% |
Morepen Laboratories Limited | -231.17 Million INR | 134.034% |
Hikal Limited | 7.96 Billion INR | 99.012% |
Indoco Remedies Limited | 6.47 Billion INR | 98.785% |
Aarti Pharmalabs Limited | 2.61 Billion INR | 96.988% |
Kilitch Drugs (India) Limited | 120.03 Million INR | 34.457% |
Mangalam Drugs & Organics Limited | 975.81 Million INR | 91.937% |
Hester Biosciences Limited | 2.29 Billion INR | 96.565% |